Supplemental Consolidated Financial Information

3 Months Ended

Mar. 31, 2025

Supplemental Consolidated Financial Information

Contract Balances

Timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable represents amounts invoiced and revenue recognized prior to invoicing when we have satisfied our performance obligation and have the unconditional right to payment. The allowance for doubtful accounts and authorized credits is estimated based upon our assessment of various factors including historical experience, the age of the accounts receivable balances, current economic conditions reasonable and supportable forecasts, and other factors that may affect our customers’ ability to pay.

The following table presents allowance for doubtful accounts and authorized credits activity for the period indicated (in millions):


	December 31, 2024		Charged/Credited to Net Income		Charges Utilized/Write-offs		March 31, 2025
Allowance for doubtful accounts	$	13	$	6	$	(2)	$	17
Allowance for authorized credits	$	24	$	2	$	—	$	26

Deferred revenue consists of fees received related to unsatisfied performance obligations at the end of the period. Due to the generally short-term duration of contracts, the majority of the performance obligations are satisfied in the following reporting period. The amount of revenue recognized for the three months ended March 31, 2025 that was included in the deferred revenue balance at the beginning of the period was $25 million. The amount of revenue recognized for the three months ended March 31, 2024 that was included in the deferred revenue balance at the beginning of the period was $28 million.

Customer accounts and funds receivable


	March 31, 2025		December 31, 2024
	(In millions)
Customer accounts (1)	$	997	$	763
Funds receivable	290		199
Customer accounts and funds receivable	$	1,287	$	962

(1)As of March 31, 2025, “Customer accounts and funds receivable” in our condensed consolidated balance sheet includes $30 million of fixed-income investments with original maturities greater than three months when purchased, which are disclosed as “Short-term investments” in these notes to the condensed consolidated financial statements.

Other current assets


	March 31, 2025		December 31, 2024
	(In millions)
Restricted cash	$	156	$	88
Prepaid expenses	139		136
Income and other tax receivable	115		115
Accounts receivable, net	108		108
Short-term derivative assets	40		68
Other	236		200
Other current assets	$	794	$	715

Accrued expenses and other current liabilities


	March 31, 2025		December 31, 2024
	(In millions)
Accrued sales and use tax and VAT	$	542	$	515
Compensation and related benefits	382		498
Accrued marketing expenses	241		222
Other current tax liabilities	176		173
Operating lease liabilities	131		118
Transaction loss reserve	103		118
Accrued general and administrative expenses	71		68
Accrued interest expense	69		45
Deferred revenue	40		32

Other	462		395
Accrued expenses and other current liabilities	$	2,217	$	2,184

Loss on equity investments and warrant, net


	Three Months Ended March 31,
	2025		2024
	(In millions)
Unrealized change in fair value of equity investment in Adevinta	$	—	$	(234)



Unrealized change in fair value of equity investment in Gmarket	—		(6)
Change in fair value of warrant	—		149



Loss on other investments	(2)		(6)
Total loss on equity investments and warrant, net	$	(2)	$	(97)

Interest income and other, net


	Three Months Ended March 31,
	2025		2024
	(In millions)
Interest income	$	77	$	61
Foreign exchange and other	4		7
Total interest income and other, net	$	81	$	68